DK1146897T3 - Anvendelse af en melanominhiberende aktivitetsfaktor (MIA) til reparation af brusk og knogle - Google Patents

Anvendelse af en melanominhiberende aktivitetsfaktor (MIA) til reparation af brusk og knogle

Info

Publication number
DK1146897T3
DK1146897T3 DK00906234T DK00906234T DK1146897T3 DK 1146897 T3 DK1146897 T3 DK 1146897T3 DK 00906234 T DK00906234 T DK 00906234T DK 00906234 T DK00906234 T DK 00906234T DK 1146897 T3 DK1146897 T3 DK 1146897T3
Authority
DK
Denmark
Prior art keywords
mia
cartilage
activity factor
inhibitory activity
bone repair
Prior art date
Application number
DK00906234T
Other languages
Danish (da)
English (en)
Inventor
Carola Dony
Gabriele Proetzel
Ulrike Leser-Reiff
Original Assignee
Carola Dony
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Carola Dony filed Critical Carola Dony
Application granted granted Critical
Publication of DK1146897T3 publication Critical patent/DK1146897T3/da

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L26/00—Chemical aspects of, or use of materials for, wound dressings or bandages in liquid, gel or powder form
    • A61L26/0009—Chemical aspects of, or use of materials for, wound dressings or bandages in liquid, gel or powder form containing macromolecular materials
    • A61L26/0028—Polypeptides; Proteins; Degradation products thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L27/00—Materials for grafts or prostheses or for coating grafts or prostheses
    • A61L27/14—Macromolecular materials
    • A61L27/22—Polypeptides or derivatives thereof, e.g. degradation products
    • A61L27/227—Other specific proteins or polypeptides not covered by A61L27/222, A61L27/225 or A61L27/24
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/08—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Organic Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Epidemiology (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Dermatology (AREA)
  • Oral & Maxillofacial Surgery (AREA)
  • Transplantation (AREA)
  • Materials Engineering (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Rheumatology (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Materials For Medical Uses (AREA)
  • Medicinal Preparation (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
DK00906234T 1999-01-28 2000-01-27 Anvendelse af en melanominhiberende aktivitetsfaktor (MIA) til reparation af brusk og knogle DK1146897T3 (da)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
EP99101315A EP1025871A1 (fr) 1999-01-28 1999-01-28 Utilisation d'un facteur à activité inhibitrice du mélanome pour la réparation de cartilage et des os
PCT/EP2000/000623 WO2000044401A1 (fr) 1999-01-28 2000-01-27 Utilisation d'un facteur d'activite inhibitrice de melanome (mia) pour la reparation de cartilages et d'os

Publications (1)

Publication Number Publication Date
DK1146897T3 true DK1146897T3 (da) 2003-02-03

Family

ID=8237403

Family Applications (1)

Application Number Title Priority Date Filing Date
DK00906234T DK1146897T3 (da) 1999-01-28 2000-01-27 Anvendelse af en melanominhiberende aktivitetsfaktor (MIA) til reparation af brusk og knogle

Country Status (11)

Country Link
US (1) US6890897B1 (fr)
EP (2) EP1025871A1 (fr)
JP (2) JP4800483B2 (fr)
AT (1) ATE224731T1 (fr)
AU (1) AU765929B2 (fr)
CA (1) CA2361238C (fr)
DE (1) DE60000501T2 (fr)
DK (1) DK1146897T3 (fr)
ES (1) ES2180514T3 (fr)
PT (1) PT1146897E (fr)
WO (1) WO2000044401A1 (fr)

Families Citing this family (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2003035128A1 (fr) * 2001-10-25 2003-05-01 Japan Science And Technology Agency Substance biologique composite
WO2003066083A1 (fr) * 2002-02-04 2003-08-14 Sumitomo Pharmaceuticals Company, Limited Preparations pour le traitement de fracture osseuse de deperdition osseuse ou d'augmentation la densite osseuse
US7473678B2 (en) 2004-10-14 2009-01-06 Biomimetic Therapeutics, Inc. Platelet-derived growth factor compositions and methods of use thereof
NZ571113A (en) 2005-11-17 2012-02-24 Biomimetic Therapeutics Inc Maxillofacial bone augmentation using rhpdgf-bb and a biocompatible matrix
CA2641860C (fr) 2006-02-09 2015-07-14 Biomimetic Therapeutics, Inc. Compositions et methodes pour le traitement d'os
US9161967B2 (en) 2006-06-30 2015-10-20 Biomimetic Therapeutics, Llc Compositions and methods for treating the vertebral column
CA2656278C (fr) 2006-06-30 2016-02-09 Biomimetic Therapeutics, Inc. Compositions et procedes destines au traitement de lesions de la coiffe des rotateurs
US7671014B2 (en) * 2006-08-14 2010-03-02 Warsaw Orthopedic, Inc. Flowable carrier matrix and methods for delivering to a patient
ES2708851T3 (es) * 2006-10-06 2019-04-11 Bionet Pharma Gmbh Un implante del núcleo pulposo espinal
WO2008073628A2 (fr) 2006-11-03 2008-06-19 Biomimetic Therapeutics, Inc. Compositions et procédés pour procédures arthrodétiques
AU2009212151C1 (en) 2008-02-07 2015-09-17 Biomimetic Therapeutics, Llc Compositions and methods for distraction osteogenesis
US9616153B2 (en) 2008-04-17 2017-04-11 Warsaw Orthopedic, Inc. Rigid bone graft substitute
NZ602861A (en) 2008-09-09 2014-03-28 Biomimetic Therapeutics Llc Platelet-derived growth factor compositions and methods for the treatment of tendon and ligament injuries
EP2538791B1 (fr) 2010-02-22 2015-04-08 BioMimetic Therapeutics, LLC Compositions de facteur de croissance dérivé des plaquettes et procédés pour le traitement de tendinopathies
EP2563809B1 (fr) 2010-04-27 2020-04-01 Scil Technology GmbH Préparation aueuse stable de mia/cd-rap
WO2018129470A1 (fr) * 2017-01-09 2018-07-12 The Board Of Trustees Of The Leland Stanford Junior University Inversion de signalisation hedgehog déficiente restaurant la régénération squelettique déficiente

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4919929A (en) * 1984-02-01 1990-04-24 Stolle Research & Development Corporation Mammal immunization
AU651421B2 (en) * 1990-11-30 1994-07-21 Celtrix Pharmaceuticals, Inc. Use of a bone morphogenetic protein in synergistic combination with TGF-beta for bone repair
AU7531294A (en) * 1993-07-20 1995-02-20 Boehringer Mannheim Gmbh Melanoma-inhibiting protein
TW369414B (en) * 1994-09-30 1999-09-11 Yamanouchi Pharma Co Ltd Bone formation transplant
US6027742A (en) * 1995-05-19 2000-02-22 Etex Corporation Bioresorbable ceramic composites
JPH10194987A (ja) * 1997-01-14 1998-07-28 Youtai Iwamoto 骨・軟骨形成用組成物
US7041641B2 (en) * 1997-03-20 2006-05-09 Stryker Corporation Osteogenic devices and methods of use thereof for repair of endochondral bone and osteochondral defects
EP0909954B1 (fr) * 1997-10-16 2003-11-26 Scil Technology Holding GmbH Détection des maladies des cartilages par MIA

Also Published As

Publication number Publication date
EP1146897A1 (fr) 2001-10-24
PT1146897E (pt) 2003-02-28
US6890897B1 (en) 2005-05-10
ES2180514T3 (es) 2003-02-16
CA2361238A1 (fr) 2000-08-03
DE60000501T2 (de) 2003-02-13
AU765929B2 (en) 2003-10-02
AU2799000A (en) 2000-08-18
JP2011084574A (ja) 2011-04-28
EP1025871A1 (fr) 2000-08-09
CA2361238C (fr) 2010-08-10
JP4800483B2 (ja) 2011-10-26
DE60000501D1 (de) 2002-10-31
EP1146897B1 (fr) 2002-09-25
WO2000044401A1 (fr) 2000-08-03
ATE224731T1 (de) 2002-10-15
JP2002537229A (ja) 2002-11-05

Similar Documents

Publication Publication Date Title
DK1146897T3 (da) Anvendelse af en melanominhiberende aktivitetsfaktor (MIA) til reparation af brusk og knogle
NO962304L (no) BMP-12, BMP-13 og sene-induserende sammensetninger derav
ATE253385T1 (de) Hochmineralisierte osteogene schwammzusammensetzungen und ihre verwendung
DE69528058D1 (de) Bmp-9 zusammensetzungen
DK0796855T3 (da) Hæmmere af knogleresorption og vitronectin-receptorantagonister
DE69031939D1 (de) Osteoinduktive zusammensetzungen
DE59711081D1 (de) Marknagelsystem zur frakturheilung bzw. knochenverlängerung
DE69926800D1 (de) Benzoheterozyklen und ihre verwendung als mek inhibitoren
ATE371650T1 (de) Cycloalkyl-derivate als inhibitoren der knochenresorption und vitronectinrezeptor- antagonisten
DE69704877D1 (de) Verwendung von anti-mikrotubuli mitteln zur behandlung und prophylaxe der multiplen sclerose
ATE335438T1 (de) Nagel und schraube für chirurgisches fixationssystem
DK1690874T3 (da) BMP-12, BMP-13 og sene-inducerende sammensætninger deraf
NO20005928D0 (no) Bicykliske pyrimidiner og bicykliske 3,4-dihydropyrimidiner som inhibitorer av cellulær proliferasjon
NO973400D0 (no) Nye aminoderivater som inhibitorer av benresorpsjon og vitronektinreseptorantagonister
ATE392869T1 (de) Artikulierbares implantatsystem
DE59907286D1 (de) Marknagel zur Knochendistraktion
DE69427345D1 (de) Verwendung von bisphosphonaten in der knochenchirurgie
EE9900006A (et) Uued amidinoderivaadid ja nende kasutamine trombiini inhibiitoritena
DE59711220D1 (de) Verbindungen mit verbesserter knorpel- und/oder knocheninduzierender aktivität
DE60221804D1 (de) Benzimidazolderivate zur ige-modulierung und zellproliferationshemmung
ATE277902T1 (de) Amidinoderivate und ihre verwendung als thrombininhibitoren
DK1027086T3 (da) Formede legemer til anvendelse som implantater i humanmedicin og metode til fremstilling af sådanne formede legemer
DE68913991D1 (de) Implantat zur verwendung in der knochenchirurgie.
ATE227278T1 (de) Substituierte benzylamine-derivate und ihre verwendung zur behandlung von depression
DE60019389D1 (de) Chirurgischer Schwenkhaltering zur Verwendung in der Augenchirurgie